Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Fallopian tube epithelium lines the interior of the fallopian tubes, which connect the ovaries to the uterus and provide the site for fertilization. This specialized epithelial layer is primarily composed of ciliated cells (which facilitate ovum transport), secretory cells (which provide a nutritive environment for gametes and early embryos), and less abundant peg and basal cells (thought to include stem-like or progenitor cell populations). The epithelium is hormonally regulated and undergoes cyclic changes during the menstrual cycle. Recent research has implicated fallopian tube epithelial cells, especially secretory cells, as the probable cell of origin for most high-grade serous ovarian carcinomas. While individual molecular components of the epithelium (like PAX8 or FOXJ1) are studied as biomarkers, the epithelium itself is a tissue structure, not a molecular target[2][3][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fallopian tube epithelium.